User contributions
- 20:22, 5 December 2007 (diff | hist) . . (+45) . . 20.109(F07): M13.1 and MDS titers (→Green Team)
- 20:21, 5 December 2007 (diff | hist) . . (+271) . . 20.109(F07): M13.1 and MDS titers (→Green Team)
- 20:16, 5 December 2007 (diff | hist) . . (+270) . . 20.109(F07): M13.1 and MDS titers (→Green Team)
- 17:10, 16 November 2007 (diff | hist) . . (+13) . . 20.109(F07): ECD experimental variations (→W/F lab)
- 17:08, 16 November 2007 (diff | hist) . . (+4) . . 20.109(F07): ECD experimental variations (→W/F lab)
- 21:40, 14 November 2007 (diff | hist) . . (+36) . . 20.109(F07): ECD experimental variations (→W/F lab)
- 19:13, 9 November 2007 (diff | hist) . . (+3) . . 20.109(F07): ECD experimental variations (→W/F lab)
- 18:49, 6 November 2007 (diff | hist) . . (0) . . 20.109(F07): Module 2 oral presentations (→RNAi in other different cell types)
- 18:48, 6 November 2007 (diff | hist) . . (+55) . . 20.109(F07): Module 2 oral presentations (→RNAi in other different cell types)
- 15:31, 12 September 2007 (diff | hist) . . (+33) . . 20.109(F07):People (→Wednesday/Friday lab section)
